alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia]
- RxCUI
- 1013867
- RxNorm name
- alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia]
- Display name
- alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia]
- Full name
- alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:06
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125325 | Glassia | Alpha-1-Proteinase Inhibitor (Human) | 351(a) | Rx | 2026-10-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GLASSIA | ALPHA.1-PROTEINASE INHIBITOR HUMAN | Takeda Pharmaceuticals America, Inc. | 83473cbb-48e4-42a2-81b6-4c851423da7b | 2025-12-02 | Warnings, Adverse reactions | 1013867 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 83473cbb-48e4-42a2-81b6-4c851423da7b | Glassia 1 MG Injection [PSN] · alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia] [SBD] · Glassia 1 MG Injection [SY] | 3 | 31 | These highlights do not include all the information needed to use GLASSIA safely and effectively. See full prescribing information for GLASSIA. GLASSIA ® (Alpha 1 -Proteinase Inhibitor (Human)) Injection, For Intravenous Use Initial U.S. Approval: 2010 | 20251202 |